Urinary metabolites and haemoglobin adducts as biomarkers of exposure to 1,3-butadiene: a basis for 1,3-butadiene cancer risk assessment.
- 1 June 2001
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 135-136, 695-701
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Biomarkers of Exposure to 1,3-Butadiene as a Basis for Cancer Risk AssessmentToxicological Sciences, 2000
- Quantitative and qualitative differences in the metabolism of 14C-1,3- butadiene in rats and mice: relevance to cancer susceptibilityToxicological Sciences, 1999
- Biomonitoring of exposure to ethylene oxide and propylene oxide by determination of hemoglobin adducts: correlations between airborne exposure and adduct levelsInternational Archives of Occupational and Environmental Health, 1999
- The Role of Hydrolysis in the Detoxification of 1,2:3,4-Diepoxybutane by Human, Rat, and Mouse Liver and Lungin VitroToxicology and Applied Pharmacology, 1996
- Biological monitoring of butadiene exposure by measurement of haemoglobin adductsToxicology, 1996
- Biological monitoring of exposure to benzene: a comparison between S-phenylmercapturic acid, trans,trans-muconic acid, and phenol.Occupational and Environmental Medicine, 1995
- Species Differences in Urinary Butadiene Metabolites: Comparisons of Metabolite Ratios between Mice, Rats, and HumansToxicology and Applied Pharmacology, 1994
- Species differences in urinary butadiene metabolites; identification of l,2-dihydroxy-4-(N-acetylcysteinyl)butane, a novel metabolite of butadieneCarcinogenesis, 1992